Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 2, 540 (1 November 2005) | doi:10.1038/ncponc0282
Treatment of acute myeloid leukemia with gefitinib: clinical trials recommended
Abstract
Stegmaier K et al. (2005) Gefitinib (Iressa) induces myeloid differentiation of acute myeloid leukemia. Blood 106: 2841–2848 Investigators have identified an FDA-approved drug that increases the degree of myeloid maturation in patients with mutations in differentiation-promoting transcription factors.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
